CREATE Medicines is a biotechnology company developing in vivo CAR therapies focused on both autoimmune diseases and oncology.
The company is advancing repeat-dose capable CD19-targeted in vivo CAR-T therapies and dual CAR programs such as CD19 x BCMA, leveraging its platform to enable targeted, repeat-administered cellular reprogramming.
Leadership & Board
Current Number of Employees47
Current LinkedIn Followers10,153
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$122M
Total Amount Raised$122M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$122M
Latest Funding Amount$122M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
CREATE Medicines had 47 employees as of September 14, 2026. The number of employees increased by 1 (2.17%) week-over-week.
47Latest Employee Count
1(2.17%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
CREATE Medicines had 10,153 followers as of September 14, 2026. The number of followers increased by 15 (0.15%) week-over-week.
10,153Latest Followers Count
15(0.15%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.